Bristol Readies For Glucophage Generics: Adds 600 Reps, Refiles Vanlev

Bristol-Myers Squibb will expand its sales force in 2002 despite an expected $1.7 bil. drop in Glucophage revenues due to the launch of metformin generics

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet